Enzon Pharmaceuticals, Inc. (BST:EZ1)

Market Cap	7.25M
Revenue (ttm)	24.06K
Net Income (ttm)	-1.24M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	953
Open	0.0755
Previous Close	0.0795
Day's Range	0.0755 - 0.0755
52-Week Range	0.0485 - 0.2300
Beta	n/a
RSI	53.41
Earnings Date	Aug 8, 2025

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: EZ1

Financial Performance

Financial numbers in USD